Association between in-vitro fertilization, birth and melanoma

Melanoma Research

Volumn 23, Issue 6, 2013, Pages 489-495

  Stewart, Louise M ^a   Holman, C D'Arcy J ^a   Finn, Judith C ^c,e   Preen, David B ^a   Hart, Roger ^b,d  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c CURTIN UNIVERSITY   (Australia)

^d Bethesda Hospital   (Australia)

^e MONASH UNIVERSITY   (Australia)

Author keywords

birth; cohort studies; epidemiology; in vitro fertilization; melanoma; parity

Indexed keywords

ADULT; ARTICLE; AUSTRALIA; CANCER INCIDENCE; CANCER REGISTRY; CHILDBIRTH; COHORT ANALYSIS; CUTANEOUS MELANOMA; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FOLLOW UP; HELP SEEKING BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; MELANOMA; NULLIPARA; PARITY; PRIORITY JOURNAL;

ADULT; AUSTRALIA; COHORT STUDIES; FEMALE; FERTILIZATION IN VITRO; HUMANS; INFERTILITY, FEMALE; MELANOMA; NEOPLASM INVASIVENESS; PARITY; PARTURITION; PREGNANCY; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84887619882     PISSN: 09608931     EISSN: 14735636     Source Type: Journal    
DOI: 10.1097/CMR.0000000000000019     Document Type: Article

References (45)

1. Australian Institute of Health and Welfare and Australasian Association of Cancer Registries. Cancer in Australia: an overview, 2012. Cancer series no. 74. Cat. no. CAN 70; 2012. Available at: http://www.aihw.gov.au/ publication-detail/?id = 60129542359. [Accessed 4 February 2013]
2. Snell RS, Bischitz PG. The effect of large doses of estrogen and estrogen and progesterone on melanin pigmentation. J Invest Dermatol 1960; 35: 73-82
3. Hasselquist MB, Goldberg N, Schroeter A, Spelsberg TC. Isolation and characterization of the estrogen receptor in human skin. J Clin Endocrinol Metab 1980; 50:76-82
4. Thornton M, Taylor AH, Mulligan K, Al-Azzawi F, Lyon CC, O'Driscoll J, et al. The distribution of estrogen receptor [beta] is distinct to that of estrogen receptor [alpha] and the androgen receptor in human skin and the pilosebaceous unit. J Investig Dermatol Symp Proc 2003; 8:100-103
5. de Giorgi V, Mavilia C, Massi D, Gozzini A, Aragona P, Tanini A, et al. Estrogen receptor expression in cutaneous melanoma: a real-time reverse transcriptase-polymerase chain reaction and immunohistochemical study. Arch Dermatol 2009; 145:30-36
6. Ohata C, Tadokoro T, Itami S. Expression of estrogen receptor beta in normal skin, melanocytic nevi and malignant melanomas. J Dermatol 2008; 35:215-221
7. Karagas MR, Zens MS, Stukel TA, Swerdlow AJ, Rosso S, Osterlind A, et al. Pregnancy history and incidence of melanoma in women: a pooled analysis. Cancer Causes Control 2006; 17:11-19
8. Kvaskoff M, Bijon A, Mesrine S, Boutron-Ruault MC, Clavel-Chapelon F. Cutaneous melanoma and endogenous hormonal factors: a large French prospective study. Am J Epidemiol 2011; 173:1192-1202
9. Lambe M, Thorn M, Sparen P, Bergstrorn R, Adami H-O. Malignant melanoma: reduced risk associated with early childbearing and multiparity. Melanoma Res 1996; 6:147-154
10. Gandini S, Iodice S, Koomen ER, Pietro AD, Sera F, Caini S. Hormonal and reproductive factors in relation to melanoma in women: current review and meta-analysis. Eur J Cancer 2011; 47:2607-2617
11. Kaae J, Andersen A, Boyd HA,Wohlfahrt J, Melbye M. Reproductive history and cutaneous malignant melanoma: a comparison between women and men. Am J Epidemiol 2007; 165:1265-1270
12. Feskanich D, Hunter DJ, Willett WC, Spiegelman D, Stampfer MJ, Speizer FE, et al. Oral contraceptive use and risk of melanoma in premenopausal women. Br J Cancer 1999; 81:918-923
13. Koomen ER, Joosse A, Herings RM, Casparie MK, Guchelaar HJ, Nijsten T. Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case-control study. Ann Oncol 2009; 20:358-364
14. Holman CD, Armstrong BK, Heenan PJ. Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors. Br J Cancer 1984; 50:673-680
15. Gefeller O, Hassan K, Wille L. Cutaneous malignant melanoma in women and the role of oral contraceptives. Br J Dermatol 1998; 138:122-124
16. Karagas MR, Stukel TA, Dykes J, Miglionico J, Greene MA, Carey M, et al. A pooled analysis of 10 case-control studies of melanoma and oral contraceptive use. Br J Cancer 2002; 86:1085-1092
17. Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Risk of cutaneous melanoma in a cohort of infertile women. Melanoma Res 1995; 5:123-127
18. Brinton LA, Melton LJ 3rd, Malkasian GD Jr, Bond A, Hoover R. Cancer risk after evaluation for infertility. Am J Epidemiol 1989; 129:712-722
19. Ron E, Lunenfeld B, Menczer J, Blumstein T, Katz L, Oelsner G, Serr D. Cancer incidence in a cohort of infertile women. Am J Epidemiol 1987; 125:780-790
20. Young P, Purdie D, Jackman L, Molloy D, Green A. A study of infertility treatment and melanoma. Melanoma Res 2001; 11:535-541
21. Hannibal CG, Jensen A, Sharif H, Kjaer SK. Malignant melanoma risk after exposure to fertility drugs: results from a large Danish cohort study. Cancer Causes Control 2008; 19:759-765
22. Dos Santos Silva I,Wark PA, McCormack VA, Mayer D, Overton C, Little V, et al. Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort. Br J Cancer 2009; 100:1824-1831
23. Modan B, Ron E, Lerner-Geva L, Blumstein T, Menczer J, Rabinovici J, et al. Cancer incidence in a cohort of infertile women. Am J Epidemiol 1998; 147:1038-1042
24. Calderon-Margalit R, Friedlander Y, Yanetz R, Kleinhaus K, Perrin MC, Manor O, et al. Cancer risk after exposure to treatments for ovulation induction. Am J Epidemiol 2009; 169:365-375
25. Venn A, Watson L, Lumley J, Giles G, King C, Healy D. Breast and ovarian cancer incidence after infertility and in vitro fertilization. Lancet 1995; 346:995-1000
26. Althuis MD, Scoccia B, Lamb EJ, Moghissi KS,Westhoff CL, Mabie JE, et al. Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs. Am J Obstet Gynecol 2005; 193:668-674
27. Stewart LM, Holman CD, Hart R, Bulsara MK, Preen DB, Finn JC. In vitro fertilization and breast cancer: is there cause for concern? Fertil Steril 2012; 98:334-340
28. Stewart LM, Holman CDJ, Aboagye-Sarfo P, Finn JC, Preen DB, Hart R. In vitro fertilization, endometriosis, nulliparity and ovarian cancer risk. Gynecol Oncol 2013; 128:260-264
29. Stewart LM, Holman CDJ, Finn JC, Preen DB, Hart R. In vitro fertilization is associated with an increased risk of borderline ovarian tumors. Gynecol Oncol 2013; 129:372-376
30. Data Linkage Western Australia, Perth, WA. Enabling health and medical research in Western Australia. 2011. Available at: http://www.datalinkagewa. org/. [Accessed 5 February 2013]
31. Holman CD, Bass AJ, Rouse IL, Hobbs MS. Population-based linkage of health records in Western Australia: development of a health services research linked database. Aust N Z J Public Health 1999; 23: 453-459
32. Australian Bureau of Statistics. Information paper: An Introduction to Socio- Economic Indexes for Areas (SEIFA), 2006. ABS catalogue no 2039.0. 2008. Available at: http://www.abs.gov.au/ausstats/absnsf/mf/2039.0/. [Accessed 25 July 2012]
33. Hosmer DW, Lemeshow S, May S. Applied survival analysis: regression modeling of time-to-event data. 2nd ed. Hoboken: John Wiley and Sons; 2008
34. Markovic SN, Erickson LA, Rao RD, McWilliams RR, Kottschade LA, Creagan ET, et al. Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc 2007; 82:364-380
35. Garbe C, Leiter U. Melanoma epidemiology and trends. Clin Dermatol 2009; 27:3-9
36. Dennis LK, Vanbeek MJ, Beane Freeman LE, Smith BJ, Dawson DV, Coughlin JA. Sunburns and risk of cutaneous melanoma: does age matter? A comprehensive meta-analysis. Ann Epidemiol 2008; 18:614-627
37. Mar V, Wolfe R, Kelly JW. Predicting melanoma risk for the Australian population. Australas J Dermatol 2011; 52:109-116
38. Veierod MB,Weiderpass E, Thorn M, Hansson J, Lund E, Armstrong B, et al. A prospective study of pigmentation, sun exposure, and risk of cutaneous malignant melanoma in women. J Natl Cancer Inst 2003; 95:1530-1538
39. Nielsen K, Masback A, Olsson H, Ingvar C. A prospective, population-based study of 40 000 women regarding host factors, UV exposure and sunbed use in relation to risk and anatomic site of cutaneous melanoma. Int J Cancer 2012; 131:706-715
40. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Picconi O, Boyle P, et al. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer 2005; 41:45-60
41. Dobson AJ, Leeder SR. Mortality from malignant melanoma in Australia: effects due to country of birth. Int J Epidemiol 1982; 11:207-211
42. Khlat M, Vail A, Parkin M, Green A. Mortality from melanoma in migrants to Australia: variation by age at arrival and duration of stay. Am J Epidemiol 1992; 135:1103-1113
43. Levine H, Afek A, Shamiss A, Derazne E, Tzur D, Astman N, et al. Country of origin, age at migration and risk of cutaneous melanoma: a migrant cohort study of 1,100 000 Israeli men. Int J Cancer 2013; 133:486-494
44. Vandenbroucke JP. The history of confounding. Soz Praventivmed 2002; 47:216-224
45. Clegg L, Reichman M, Miller B, Hankey B, Singh G, Lin Y, et al. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study. Cancer Causes Control 2009; 20:417-435.